New cancer pill almost doubles survival time for patients
Digest more
Nanoparticle delivery vehicle targets lung cancer drugs to the lungs, boosting bioavailability 30-fold while reducing exposure to healthy organs.
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
GLP-1 RA use was also tied to lower rates of immune-related side effects, caused by the immune system becoming overactive as a result of immunotherapy treatment. Patients taking GLP-1 drugs showed significantly lower rates of fever (pyrexia) at 3 years, with a 2.5 percentage-point risk reduction, and similar protective trends at 5 years.
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49%, a new study shows.
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
What Is BCG Treatment for Bladder Cancer? Bacillus Calmette-Guérin (BCG) is the main immunotherapy used to treat early-stage bladder cancer. Immunotherapy uses your immune system to fight cancer. BCG is a type of intravesical therapy, which means a liquid ...
How much do healthy lifestyle habits, such as diet and exercise, matter after a cancer diagnosis? Adopting healthy lifestyle behaviors - such as regularly engaging in moderate-intensity exercise or